Artículo de Revisión 24 rch=vitamina+d&selectedTitle=1~150 (consultado el 27 de julio de 2016). 6.- Norman A, Henry H. Vitamin D. En: Erdman J, Macdonald I, Zeisel S. Present knowledge in nutrition. 10th Ed. Wiley- Blackwell; 2012. Pp. 199-213. 7.- Anglin R, Samaan Z, Walter S, McDonald S. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 2013; 202: 100-7. 8.- Song M, Nishihara R, Wang M, Chang A, Qian Z, Inamura K, et al. Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumor immunity status. Gut 2016; 65: 296-304. 9.- Organización Mundial de la Salud (OMS). Evaluación del riesgo de fractura y su aplicación en la detección de la osteoporosis postmenopáusica. http://apps.who.int/ iris/bitstream/10665/37205/1/WHO_ TRS_843_spa.pdf Consultado el 25 de marzo de 2016. 10.- Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S, et al. Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo 2016; 68: 1-39. 11.- Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C, EU Review Panel of IOF. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 2013; 8: 137. Publicación electrónica en avance. 12.- Clark P, Chico G, Carlos F, Zamudio F, Pereira MR, Zanchetta J, et al. Osteoporosis in Latin America: panel expert review. Medwave 2013; 13: e5791 Consultado el 25 de marzo de 2016. 13.- Mautalen C, Schianchi A, Sigal D, Gianetti G, Vidan V, Bagur A, et al. Prevalence of Osteoporosis in Women in Buenos Aires Based on Bone Mineral Density at the Lumbar Spine and Femur. J Clin Densitom 2016; 19:471-6. 14.- Arinoviche R, Arriagada M. Algunos Osteopo rosis . Parte I - Gene ralidades - M. Cabezón J. et al. datos de la epidemiología de la osteoporosis en Chile. En: Arinoviche R y Arriagada M. Temas de osteoporosis y otras enfermedades óseas. FUNDOP; 2012. pp. 32-51. 15.- International Osteoporosis Foundation. www.iofbonehealth.org/sites/default/files/ media/PDFs/Regional%20Audits/2012- Latin_America_Audit-Chile-ES_0_0.pdf. Consultado el 6 de junio de 2016. 16.- International Osteoporosis Foundation. Carga global de la osteoporosis en cifras. www.iofbonehealth.org/sites/default/ files/media/PDFs/Fact%20Sheets/2014- Factsheet-Burden_Osteoporosis-A4-ES. pdf. Consultado el 6 de junio de 2016. 17.- Weaver C, Gordon C, Janz K, Kalkwarf H, Lappe J, Lewis R, et al. The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 2016; 27: 1281-386. 18.- Sheu A, Diamond T. Secondary osteoporosis. Aust Prescr 2016; 39: 85-7. 19.- O’Connor KM. Evaluation and treatment of osteoporosis. Med Clin North Am 2016; 100: 807-26. 20.- Aparisi F. Enfermedades metabólicas, endocrinas y tóxicas del hueso. En: del Cura J, Pedraza S, Gayete A. Radiología esencial. Vol I. Ed. Médica Panamericana; 2011; 844-53. 21.- Kann P, Pfützner A, Delling G, Schulz G, Meyer S. Transiliac bone biopsy in osteoporosis: frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14 years. Clin Rheumatol 2006; 25: 30-4. 22.- Kelly D. Medicine. Irisin, light my fire. Science 2012; 336: 42-3. 23.- Black D, Rosen C. Postmenopausal osteoporosis. N Engl J Med 2016; 374: 254-62. 24.- Moyer VA, US Preventive Services Task Force. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013; 158: 691-6. 25.- Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in postmenopausal women and older men. Cochrane Database Syst Rev 2014; (4): CD000227. 26.- Castrogiovanni P, Trovato F, Szychlinska M, Nsir H, Imbesi R, Musumeci G. The importance of physical activity in osteoporosis. From the molecular pathways to the clinical evidence. Histol Histopathol 2016; 31: 1183-94. 27.- Zhu K, Prince R. Lifestyle and osteoporosis. Curr Osteoporos Rep 2015; 13: 52-9. 28.- Slatkovska L, Alibhai SM, Beyene J, Cheung A. Effect of wholebody vibration on BMD: a systematic review and metaanalysis. Osteoporos Int 2010; 21: 1969-80. 29.- Cosman F, de Beur S, LeBoff M, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014; 25: 2359-81. 30.- Vescini F, Attanasio R, Balestrieri A. Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest 2016; 39: 807-34. 31.- Adler R, El-Hajj Fuleihan G, Bauer D, Camacho P, Clarke B, Clines GA, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 2016; 31: 16-35. 32.- Maraka S, Kennel K. Bisphosphonates for the prevention and treatment of osteoporosis. BMJ 2015; 351: h3783. 33.- Rosen H. Calcium and vitamin D supplementation in osteoporosis. Up To Date 2016. http://www. uptodate.com/contents/calciumand vitamin-d-supplementation-inosteoporosis? source=see_link§ion Name=Vitamin+D&anchor=H14#H14 (Consultado el 5 de octubre de 2016). Gastroenterol. latinoam 2017; Vol 28, Nº 1: 16-24
Gastro-1-2017
To see the actual publication please follow the link above